About DGNCT
DGNCT LLC, operating as Diagnocat, is a healthcare AI company specializing in artificial intelligence solutions for dental imaging analysis. Their platform, Diagnocat, is a cloud-based AI system designed to analyze various radiographic formats, including Cone Beam Computed Tomography (CBCT) volumes, panoramic radiographs, and intraoral x-rays. The company’s technology utilizes convolutional neural networks (CNNs) to identify and analyze a wide range of dental conditions, such as caries, dental restorations, missing teeth, and periodontal bone loss. Diagnocat aims to enhance diagnostic precision, streamline treatment planning, and optimize patient management workflows by providing algorithmic second opinions and automated reporting.
For physicians, Diagnocat offers a comprehensive tool to support clinical decision-making and improve communication with patients. The platform holds two FDA 510(k) clearances (K252934 and K251072) for specific functionalities, including AI second read on CBCT for periapical radiolucency and Segmentron Viewer for segmentation and visualization. Diagnocat’s capabilities extend to analyzing over 40 different possible conditions on 2D images and more than 60 on 3D radiographs, generating automated radiological reports, and auto-segmenting scans into exportable STL models for applications like surgical-guide planning. While the company has an international presence since 2017 with over 1,000 clinics in 54 countries and Health Canada clearance, its US track record is more recent, with a launch in late 2025. It is particularly compelling for practices seeking a single AI platform for both 2D and 3D dental imaging.
Focus Areas
Business Intelligence
| Technology | Cloud-based software, web application, Convolutional Neural Networks (CNNs), deep learning models (U-Net-like and Mask R-CNN architectural models) |
What Physicians Need to Know
For physicians, DGNCT's Diagnocat offers an AI-powered 'second opinion' that can reinforce clinical decision-making and enhance patient communication regarding treatment rationale. The system's ability to analyze both 2D and 3D images, generate detailed reports, and create 3D models can streamline workflows for specialists in orthodontics, oral surgery, and implantology. The visual and easy-to-understand reports can also improve patient understanding and treatment acceptance. While the platform offers extensive capabilities, it's important to verify which specific report types are FDA-cleared for clinical use in your region.
DGNCT's Diagnocat is a cloud-based AI platform designed to integrate with a clinic's information system, X-ray equipment, and intraoral scanners, centralizing patient data in one interface. It supports DICOM compatibility, ensuring usability and integration capabilities with other software. The platform also allows for the export of segmented structures as STL models, which can be used with other treatment planning programs.
Products by DGNCT
What the Web Says
DGNCT appears to be primarily associated with Diagnocat, an AI-powered dental imaging analysis platform, and DGN Technologies Inc., a recruiting and staffing company. Reviews for DGN Technologies Inc. (the staffing company) are generally positive, highlighting good pay, benefits, and a supportive culture. For Diagnocat (the product), reviews emphasize its unique capabilities in 3D dental imaging analysis, particularly CBCT scans, and its FDA clearances. However, some limitations and a lack of published pricing are noted for Diagnocat.
Overall: MixedStrengths
- Good pay and benefits (DGN Technologies Inc.)
- Supportive culture and management (DGN Technologies Inc.)
- Opportunities for growth and learning (DGN Technologies Inc.)
- Reliable pay and responsive HR (DGN Technologies Inc.)
- FDA-cleared AI for CBCT analysis (Diagnocat)
- Comprehensive 2D+3D imaging analysis (Diagnocat)
Limitations
- Management doesn't always keep promises (DGN Technologies Inc.)
- High rejection rate for H1B and PERM processing (DGN Technologies Inc.)
- Newer to the US market with limited domestic clinical validation data (Diagnocat)
- CBCT integration workflow may require verification with specific scanner manufacturers (Diagnocat)
- Pricing not published (Diagnocat)
- International marketing for Diagnocat is broader than US clearance
Based on reviews from: Indeed.com, DGN Technologies website, AI Dental Tools, MDPI, Reddit, G2, Capterra
Last updated: 2026-10-24
Videos
News, demos, and interviews about DGNCT.
Videos load interactively. If none appear, search YouTube for DGNCT →
Press & Coverage
Frequently Asked Questions
Related Companies
OrthoAI is an innovative AI-powered platform designed to assist orthopedic surgeons in clinical decision-making, surgical planning, and patient care. It functions as a 24/7 surgical companion, providing evidence-based answers to complex clinical questions, surgical techniques, and theoretical queries. The platform leverages a meticulously curated database developed by expert orthopedic surgeons, integrates with PubMed for the […]
NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]
Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]
The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]
Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]
Philips (Cardiologs) is a healthcare AI company that specializes in transforming cardiac diagnostics through medical-grade artificial intelligence and cloud technology. Their core offering is the Cardiologs Holter platform, which utilizes deep neural networks to analyze continuous ambulatory ECGs. This platform is designed to streamline ECG analysis, reduce reporting errors, and accelerate diagnostic reporting, ultimately empowering […]